Overall survival from diagnosis for donor versus no-donor for Ph-negative patients. Estimation of the effect of sibling donor transplant versus chemotherapy in standard-risk patients.

Published with permission from Goldstone AH, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008;111:1827–33.²⁶